Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cerebral Folate Deficiency, Autism, and the Role of Leucovorin.

The New England journal of medicine·2026
Same author

Reinventing chemotherapy.

The oncologist·2025
Same author

Diffuse Large B-Cell Lymphoma Treated With R-CHOP in a Resource-Limited Setting in South Africa: A Real-World Study.

The oncologist·2023
Same author

Results from the IMpower132 China cohort: Atezolizumab plus platinum-based chemotherapy in advanced non-small cell lung cancer.

Cancer medicine·2022
Same author

[Chinese Expert Consensus on Management of Special Adverse Effects 
Associated with Lorlatinib].

Zhongguo fei ai za zhi = Chinese journal of lung cancer·2022
Same author

Supporting Patients with Cancer after Dobbs v. Jackson Women's Health Organization.

The oncologist·2022

Related Experiment Video

Updated: Jan 28, 2026

Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens
10:49

Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens

Published on: January 21, 2019

21.5K

Immuno-Oncology in China.

Shun Lu1, Bruce A Chabner2

  • 1Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People's Republic of China shun_lu@hotmail.com.

The Oncologist
|March 2, 2019
PubMed
Summary

Chinese researchers are advancing immuno-oncology, a breakthrough cancer therapy. This special issue showcases their diverse research on immunotherapy for various cancers, benefiting readers with new insights.

More Related Videos

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
08:17

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

Published on: August 15, 2019

15.3K
Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

16.5K

Related Experiment Videos

Last Updated: Jan 28, 2026

Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens
10:49

Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens

Published on: January 21, 2019

21.5K
A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
08:17

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

Published on: August 15, 2019

15.3K
Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

16.5K

Area of Science:

  • Oncology
  • Immunology

Background:

  • Immuno-oncology represents a significant advancement in cancer treatment.
  • Chinese researchers are making substantial contributions to immuno-oncology research.

Discussion:

  • This special issue focuses on immunotherapy research from China.
  • It covers diverse perspectives on applying immunotherapy to various cancer types.

Key Insights:

  • Highlights the growing role of Chinese scientists in immuno-oncology.
  • Showcases a range of immunotherapy strategies and applications.

Outlook:

  • Provides readers with valuable insights into current immuno-oncology research trends.
  • Underscores the collaborative and evolving nature of cancer immunotherapy research.